VivoSim Labs, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
VivoSim Labs, Inc. (VIVS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 0 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-12
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 0.00 shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 474.00 shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 1.33K shares, a 78.01% decline year-over-year.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2026 was 5.71K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-12 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-12 | 474.00 shares derived: sum of 3 quarters · filed 2026-08-12 | 1.81K shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | 474.00 shares derived: sum of 2 quarters · filed 2026-07-14 | 1.81K shares derived: sum of 3 quarters · filed 2026-07-14 | 5.71K shares 10-K · filed 2026-07-14 |
| 2025-12-31 | 474.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | 1.81K shares derived: sum of 2 quarters · filed 2026-02-11 | 5.71K shares 10-Q · filed 2026-02-11 | |
| 2025-09-30 | 1.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | 5.24K shares 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 3.90K shares 10-Q · filed 2025-08-12 | |||
| 2024-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-19 | 6.07K shares derived: sum of 2 quarters · filed 2025-02-19 | 6.07K shares 10-Q · filed 2025-02-19 | |
| 2024-09-30 | 6.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-08 | 6.07K shares 10-Q · filed 2024-11-08 | ||
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-05 | |||
| 2023-12-31 | 176.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | 333.63K shares 10-Q · filed 2024-02-08 | ||
| 2023-09-30 | 157.08K shares 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |